News ReleaseView printer-friendly version
Quidel to Present at Upcoming Conferences
Raymond James & Associates40th Annual Institutional Investors Conferenceto be held at the J.W. Marriott Grande Lakeshotel in Orlando, Floridaon Wednesday, March 6, 2019at 12:10 p.m. Eastern Time( 9:10 a.m. Pacific Time).
Barclays Global Healthcare Conference, to be held at the Loews Miami Beach hotel in Miami Beach, Floridaon Thursday, March 14, 2019at 9:00 a.m. Eastern Time( 6:00 a.m. Pacific Time).
A live webcast and audio archive of each presentation will be available via the Investor Relations section of the company’s website at http://ir.quidel.com or by clicking the links below.
Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. A replay of the webcast will also be available on the company’s website for 14 days.
Quidel Corporation serves to enhance the health and well-being of people
around the globe through the development of diagnostic solutions that
can lead to improved patient outcomes and provide economic benefits to
the healthcare system. Marketed under the Sofia®, QuickVue®, D3® Direct
Detection, Thyretain®, Triage® and InflammaDry® leading brand names, as
well as under the new Solana®, AmpliVue® and Lyra®
molecular diagnostic brands, Quidel’s products aid in the detection and
diagnosis of many critical diseases and conditions, including, among
others, influenza, respiratory
syncytial virus, Strep A, herpes, pregnancy, thyroid
disease and fecal
Chief Financial Officer
Media and Investors Contact: